Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease.

Published in: The Annals of pharmacotherapy (2021)

The findings from phase 3 trials support the efficacy and safety of triple therapy in COPD. Future studies are needed to confirm potential mortality benefit and the role of triple therapy in patients without an exacerbation history.

Keyphrases

chronic obstructive pulmonary disease
risk factors
type diabetes
current status
combination therapy
intensive care unit
risk assessment
air pollution
human health